Tell Great NonProfits how we have been doing, please

Every couple of years we ask our readers to let Great NonProfits know if we are doing a good job for you. And it’s that time again. … READ MORE …

Liquid biopsies, ctDNA, and the diagnosis and management of cancers

The American Society of Clinical Oncology (ASCO) and the College of Pathologists (CAP) have just issued a joint review of available information on clinical use of “liquid biopsies” to assess circulating levels of tumor DNA (ctDNA). … READ MORE …

Are genomic tests “up to snuff” for routine use in prognosis of prostate cancer risk?

The Intergroupe Coopérateur Francophone de Recherche en Onco-urologie (ICFuro) has just published a review of the available evidence on the clinical validity and utility of six prognostic biomarkers available for the assessment of prostate cancer-related risk. … READ MORE …

A thorough review of immunotherapeutics in the treatment of prostate cancer

A new review article has just been published in the journal Critical Reviews in Hematology Oncology. It is probably a current “must read” for support group leaders and for any patients who are interested in the idea of using immunotherapy as a treatment for progressive and advanced forms of prostate cancer. … READ MORE …

State of the art lectures at the EAU meeting in London

Recently posted on the UroToday web site are summaries of four “state-of-the-art” lectures on prostate cancer and its management presented a couple of weeks ago at the annual meeting of the European Association of Urology is London. … READ MORE …

A pathological “take” on the potential role of focal therapy

Various forms of focal therapy are now being used by some physicians to treat selected patients with well-identified, usually relatively small, “dominant” or “index” tumors that are confined to highly defined areas of the prostate. … READ MORE …

The current role of sipuleucel-T in the management of advanced prostate cancer

A new review article has provided a detailed update on the current state of knowledge about the use of sipuleucel-T (Provenge®) in the treatment of advanced forms of prostate cancer. … READ MORE …

Management of men with bone metastasis over time

A new review article in issue 2 of Everyday Urology addresses the topic of bone mets, quality of life, and related factors in the management of advanced and metastatic prostate cancer over time. … READ MORE …

A useful new series of clinical review articles

At least some of our readers will be interested in knowing about a series of straightforward, clinical review articles on various aspects of prostate cancer diagnosis and management that have just started to be published on line in a new journal called Everyday Urology – Oncology Insights. … READ MORE …

How cancer metastasizes — a large-scale review

For those who are really interested in the slow if steady progress toward an understanding of why and how cancer cells metastasize out of the organ they are formed in (e.g., the prostate) to spread through the body (e.g., the spine, other bones, the lungs, the liver, etc.) … READ MORE …

Focal cryotherapy in the treatment of localized prostate cancer

A recent article in Expert Review of Anticancer Therapy has assessed the effectiveness and safety of focal cryotherapy in the first- and second-line treatment of localized prostate cancer. … READ MORE …

RALP in treatment of high-risk prostate cancer: a systematic review

Researchers from City of Hope in Los Angeles have conducted an expert, systematic review of the published literature on the use of robot-assisted, laparoscopic radical prostatectomy (RALP) in the management of high-risk, localized prostate cancer. … READ MORE …

New review of current practice in use of LHRH receptor agonists and antagonists

The full text of a recent review on the use of LHRH receptor agonists (e.g., leuprolide acetate, goserelin acetate) asnd LHRH receptor antagonists (e.g., degarelix) has recently been published by Shore et al. in Prostate Cancer and Prostatic Diseases. The full text of the article is also available on line on the Medscape Oncology web site.

Active surveillance — a comprehensive review (with comment)

In another article in European Urology, Dall’Era et al. have provided a thorough review of published outcome data from the seven largest known series of patients being managed under active surveillance (AS). Unfortunately the full text of this article is not available on line. … READ MORE …

Expert video-discussion on evolution in the management of late stage prostate cancer

Here is a link to a recent 20-minute video-discussion on the Medscape web site between an number of European experts on evolutions in the management of castration-resistant (and earlier forms of) prostate cancer. … READ MORE …